Development of antibodies to feline IFN-γ as tools to elucidate the cellular immune responses to FeLV

Journal of Immunological Methods

Volumn 279, Issue 1-2, 2003, Pages 69-78

  Graham, Elizabeth M ^a   Jarrett, Oswald ^a   Flynn, J Norman ^a  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

Antifeline antibodies; Feline cytokines; Feline leukaemia virus; IFN

Indexed keywords

BREFELDIN A; CD4 ANTIGEN; FLUORESCEIN ISOTHIOCYANATE; GAMMA INTERFERON; GAMMA INTERFERON ANTIBODY; MITOGENIC AGENT; MONOCLONAL ANTIBODY; POLYCLONAL ANTIBODY; RECOMBINANT GAMMA INTERFERON; VIRUS ANTIGEN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIBODY PRODUCTION; ANTIBODY SPECIFICITY; ARTICLE; CAT DISEASE; CELL CLONE; CELL LABELING; CELL SPECIFICITY; CELLULAR IMMUNITY; COCULTURE; CYTOKINE PRODUCTION; ENZYME LINKED IMMUNOSORBENT ASSAY; FELINE LEUKEMIA VIRUS; FEMALE; FLOW CYTOMETRY; HYBRIDOMA; IMMUNOBLOTTING; IMMUNOREGULATION; IN VITRO STUDY; LATENT PERIOD; LYMPH NODE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN PURIFICATION; PROTEIN SECRETION; SHEEP; T LYMPHOCYTE; UPREGULATION; VIRUS IMMUNITY;

FELIDAE; FELIS CATUS; MURINAE; OVIS ARIES;

EID: 0142124344     PISSN: 00221759     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-1759(03)00244-8     Document Type: Article

References (32)

1. Addie D.D., Toth S., Murray G.D., Jarrett O. Risk of feline infectious peritonitis in cats naturally infected with feline coronavirus. Am. J. Vet. Res. 56:1995;429.
2. Argyle D.J., Smith K., McBride K., Fulton R., Onions D.E. Nucleotide and predicted peptide sequence of feline interferon-gamma (IFN-γ). DNA Seq. 5:1995;169.
3. Beatty J.A., Willett B., Gault E.A., Jarrett O. A longitudinal study of feline immunodeficiency virus-specific cytotoxic T lymphocytes in experimentally infected cats, using antigen-specific induction. J. Virol. 70:1996;6199.
4. Boehm U., Klamp T., Groot M., Howard J.C. Cellular responses to interferon-γ Annu. Rev. Immunol. 15:1997;749.
5. +T cells that induce gamma interferon production in patients with localized cutaneous leishmaniasis during an early stage of infection. Infect. Immun. 70:2002;3122.
6. Czerkinsky C.C., Nilsson L.A., Nygren H., Ouchterlony O., Tarkowski A. A solid-phase enzyme-linked immunospot (ELISPOT) assay for enumeration of specific antibody-secreting cells. J. Immunol. Methods. 65:1983;109.
7. Dean G.A., Higgins J., LaVoy A., Fan Z., Pedersen N.C. Measurement of feline cytokine gene expression by quantitative-competitive RT-PCR. Vet. Immunol. Immunopath. 63:1998;73.
8. Farrar M.A., Schreiber R.D. The molecular cell biology of interferon-γ and its receptor. Annu. Rev. Immunol. 11:1993;571.
9. Flynn J.N., Keating P.K., Hosie M.J., Mackett M., Stephens E.B., Beatty J.A., Neil J.C., Jarrett O. Env-specific CTL predominate in cats protected from feline immunodeficiency virus infection by vaccination. J. Immunol. 157:1996;3658.
10. Flynn J.N., Hosie M.J., Rigby M.A., Mackay N., Cannon C.A., Dunsford T., Neil J.C., Jarrett O. Factors influencing cellular immune responses to feline immunodeficiency virus induced by DNA vaccination. Vaccine. 18:2000;1118.
11. Flynn J.N., Dunham S.P., Watson V., Jarrett O. Longitudinal analysis of feline leukaemia virus-specific cytotoxic T lymphocytes: correlation with recovery from infection. J. Virol. 76:2002;2306.
12. Fujiwara T., Oda K., Yokota Y., Takatsuki A., Ikehara Y. Brefeldin A causes disassembly of the Golgi complex and accumulation of secretory proteins in the endoplasmic reticulum. J. Biol. Chem. 263:1988;18545.
13. Hanlon L., Argyle D., Bain D., Nicholson L., Dunham S.P., Golder M.C., McDonald M., McGillivray C., Jarrett O., Neil J.C., Onions D.E. Feline leukaemia virus DNA vaccine efficiency is enhanced by coadministration with interleukin-12 (IL-12) and IL-18 expression vectors. J. Virol. 75:2001;8424.
14. Hosie M.J., Flynn J.N., Rigby M.A., Cannon C.A., Dunsford T., Mackay N., Arglye D., Willett B., Miyazawa T., Onions D., Jarrett O., Neil J.C. DNA vaccination affords significant protection against feline immunodeficiency virus infection without inducing detectable antiviral antibodies. J. Virol. 72:1998;7310.
15. Jarrett, O., 2001. Feline leukaemia virus. Encyclopedia of Life Sciences ( http://www.els.net ).
16. Jung T., Schauer U., Heusser C., Neumann C., Rieger C. Detection of intracellular cytokines by flow cytometry. J. Immunol. Methods. 159:1993;197.
17. Kakazu T., Hara J., Matsumoto T., Oshitani N., Arakawa T., Kitano A., Nakatani K., Kinjo F., Kuroki T. Type 1 T-helper cell predominance in granulomas of Crohn's disease. Am. J. Gastroenterol. 94:1999;2149.
18. Kemp K., Theander T.G., Hviid L., Garfar A., Kharazmi A., Kemp M. Interferon-γ and tumour necrosis factor-α-producing cells in humans who are immune to cutaneous leishmaniasis. Scand. J. Immunol. 49:1999;655.
19. Kohler G., Milstein C. Continuous cultures of fused cells secreting antibody of predefined specificity. 1975. Biotechnology. 24:1992;524.
20. Leutenegger C.M., Mislin C., Sigrist B., Ehrengruber M.U., Hofmann-Lehmann R., Lutz H. Quantitative real-time PCR for the measurement of feline cytokine mRNA. Vet. Immunol. Immunopath. 71:1999;291.
21. Mateu de Antonio E., Husman R.J., Hansen R., Lunney J.K., Strom D., Martin S., Zuckermann F.A. Quantitative detection of porcine interferon-gamma in response to mitogen, superantigen and recall viral antigen. Vet. Immunol. Immunopath. 61:1998;265.
22. Nylander S., Kalies I. Brefeldin A, but not monensin, completely blocks CD69 expression on mouse leukocytes: efficacy of inhibitors of protein secretion in protocols for intracellular cytokine staining by flow cytometry. J. Immunol. Methods. 224:1999;69.
23. Paltrinieri S., Parodi Cammarata M., Cammarata G., Comazzi S. Some aspects of humoral and cellular immunity in naturally occurring feline infectious peritonitis. Vet. Immunol. Immunopath. 65:1998;205.
24. Pathan A.A., Wilkinson K.A., Klenerman P., McShane H., Davidson R.N., Pasvol G., Hill A.V.S., Lalvani A. Direct ex vivo analysis of antigen-specific IFN-γ-secreting CD4 T cells in Mycobacterium tuberculosis-infected individuals: associations with clinical disease state and effect of treatment. J. Immunol. 167:2001;5217.
25. Pedersen N.C., Ho E.W., Brown M.L., Yamamoto J.K. Isolation of a T-lymphotropic virus from domestic cats with an immunodeficiency-like syndrome. Science. 235:1987;790.
26. +T cells are detectable in most individuals with active HIV-1 infection, but decline with prolonged viral suppression. Nat. Med. 5:1999;518.
27. +T cell responses associated with control of viraemia. Science. 278:1997;1447.
28. +T cells in chronic human immunodeficiency virus infection. Blood. 96:2000;3094.
29. Shtrichman R., Samuel C.E. The role of gamma interferon in antimicrobial immunity. Curr. Opin. Microbiol. 4:2001;251.
30. van Der Loos C.M., Houtkamp M.A., de Boer O.J., Teeling P., van Der Wal A.C., Becker A.E. Immunohistochemical detection of interferon-γ: fake or fact? J. Histochem. Cytochem. 49:2001;699.
31. Willett B., Flynn J.N., Hosie M.J. FIV infection of the domestic cat: an animal model for AIDS. Immunol. Today. 18:1997;182.
32. Young H.A., Hardy K.J. Role of interferon-gamma in immune cell regulation. J. Leukoc. Biol. 58:1995;373.